Althea Technologies has been contracted by GeoVax Labs to manufacture its HIV-1 DNA (AIDS) vaccine. This vaccine will be utilized in GeoVax’s Phase II trials, which are planned to start in early 2008. GeoVax chose Althea as the contract manufacturer for its DNA vaccine based on Althea’s “extensive experience in the field of DNA vaccine manufacture and its regulatory compliance history,” according to a press statement. GeoVax AIDS vaccines are designed to prevent develo...